NCT06710912

Brief Summary

The goal of this clinical trial is to learn if group acceptance and commitment therapy works to improve depressive symptoms, psychological flexibility and quality of life in adults. The main questions it aims to answer are:

  • Attend weekly ACT sessions for four weeks or undergo standard treatment for major depressive disorder.
  • Fill up four questionnaires before the intervention, after a month and at 3-month follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 7, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 26, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 29, 2024

Completed
Last Updated

November 29, 2024

Status Verified

November 1, 2024

Enrollment Period

1.6 years

First QC Date

November 26, 2024

Last Update Submit

November 26, 2024

Conditions

Keywords

acceptance and commitment therapy (ACT)group therapydepressionpsychological flexibilityquality of life

Outcome Measures

Primary Outcomes (3)

  • Depressive symptoms

    The outcome was measured by using Beck Depression Inventory (BDI)

    From enrollment to the end of treatment at 4 weeks

  • Quality of life

    The outcome was measured by using brief WHO Quality of Life (WHOQOL) questionnaire (Malay version)

    From enrollment to the end of treatment at 4 weeks

  • Psychological flexibility

    The outcome was measured using Acceptance and Action Questionnaire II Malay Version (AAQ-II)

    From enrollment to the end of treatment at 4 weeks

Secondary Outcomes (3)

  • Depressive symptoms (3 months)

    3 months post intervention

  • Quality of life (3 months)

    3 months post intervention

  • Psychological flexibility (3 months)

    3 months post intervention

Study Arms (2)

Group ACT

EXPERIMENTAL

Participants of this arm underwent 4 weeks of weekly session of acceptance and commitment therapy (ACT).

Behavioral: Group acceptance and commitment therapy (ACT)

Treatment-as-usual (TAU) group

ACTIVE COMPARATOR

The participants in this group received standard treatment for major depressive disorder

Other: Treatment as usual

Interventions

The ACT intervention module utilized in this study was adapted from Hayes foundational work on ACT and Harris. A summary of the general contents and exercises in each week was in accordance with the 6 core processes of Acceptance and Commitment Therapy based on Hayes. It was conducted in the Malay language. The same workbook with guided exercise and homework were used by all the therapists to assure standardization of the intervention to ensure that each group received similar contents in each session.

Group ACT

Standard care and follow-up for major depressive disorder

Treatment-as-usual (TAU) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • had a Beck Depression Inventory (BDI) score ranging from 10 to 29, indicating mild to moderate depression.
  • Proficient in the Malay language
  • Willing to commit to the study.

You may not qualify if:

  • Have concomitant psychotic symptoms.
  • Participated and enrolled in Cognitive Behavioural Therapy.
  • previously had participated in Acceptance Commitment Therapy.
  • had underlying substance use disorder or active substance use.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universiti Sains Malaysia

Kota Bharu, Kelantan, 16150, Malaysia

Location

Related Publications (1)

  • Rong J, Cheng P, Li D, Wang X, Zhao D. Global, regional, and national temporal trends in prevalence for depressive disorders in older adults, 1990-2019: An age-period-cohort analysis based on the global burden of disease study 2019. Ageing Res Rev. 2024 Sep;100:102443. doi: 10.1016/j.arr.2024.102443. Epub 2024 Aug 7.

    PMID: 39097004BACKGROUND

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants in the ACT group attended four sessions of Acceptance and Commitment Therapy over a four-week period with each session lasting around 90-120 minutes. The participants were divided into three subgroups, each of which included approximately 6 to 8 participants. Prior to the intervention, participants in the ACT group received a workbook which consists of information about ACT in summary. Participants in the ACT group had accessibility to the same care similar to the TAU group. Four sessions were held for each subgroup respectively which was conducted by at least two therapists trained in ACT. The ACT module was adapted from Hayes and Harris and were conducted in the Malay language. The same workbook with guided exercise and homework were used by all the therapists to assure standardization of the intervention to ensure that each group received similar contents in each session.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

November 26, 2024

First Posted

November 29, 2024

Study Start

June 1, 2022

Primary Completion

January 7, 2024

Study Completion

May 31, 2024

Last Updated

November 29, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations